Since its inception, Q-LINE BIOTECH has grown rapidly both through organic growth as well as through strategic acquisitions. Every year had been a particularly phenomenal period for Q-LINE BIOTECH as significant value has been added to the business in this way. I would like to congratulate my Q-LINE BIOTECH Team for their contribution to our sales growth and leadership abilities.
Demand for efficient and state-of-the-art healthcare services is expected to continue its upward trajectory and become increasingly sophisticated, driven by high population growth rates, plateauing government healthcare capacity and the widened scope of health insurance in the Country.
Q-LINE BIOTECH has evolved being one of the fastest growing healthcare groups in the country and is set to expand both in scale and market reach through its operating brands in addition to exploring new hospital projects. Q-LINE BIOTECH will also look at potential expansion into the wider region of the Country, with the aim of maintaining a market leadership position for all of its brands.
In the year ahead, the business environment will continue to remain challenging and competitive; intensity is likely to remain high. With our purpose driven brands, passionate employees and your continued support, I am confident that we will continue to deliver growth that is consistent, competitive, profitable and responsible. We aim at forming new strategic alliances with Government Institutional bodies and key global healthcare partners to put the Q-LINE BIOTECH on the nation’s healthcare map.
I take this opportunity to extend our thanks to the Government, our Customers, Employees, our well-wishers, Board of Directors and all other stakeholders for their wholehearted and continued support and contribution in the success of Q-LINE BIOTECH.
Get our updates always fast
Your personal data will always be safe